TAO Synergies (TAOX) Enterprise Value (2020 - 2026)
TAO Synergies' (TAOX) quarterly Enterprise Value came in at $25.5 million in Q2 2026, up 1305.52% on a YoY basis from $1.8 million in Q2 2025, and down 34.46% quarter-over-quarter from $38.9 million in Q1 2026.
Analysis
TAO Synergies (TAOX) Enterprise Value (2020 - 2026) Analysis & Trends
TAO Synergies (TAOX) has reported Enterprise Value for 7 consecutive years, with $25.5 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Enterprise Value rose 1305.52% year-over-year to $25.5 million; the trailing twelve-month figure through Jun 2026 stood at $25.5 million (up 1305.52% YoY), and the FY2025 full-year result was $6.6 million, up 151.17% from the prior year.
- Enterprise Value slipped to $25.5 million in Q2 2026 per TAOX's latest filing, from $38.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at $1.3 billion in Q1 2022 and bottomed at -$23.2 million in Q1 2024.
- Historically, Enterprise Value has averaged $212.0 million across 5 years, with a median of $32.2 million in 2026.
- The sharpest annual moves came in 2024 and 2026: Enterprise Value tumbled 126.46% in 2024, then jumped 1305.52% in 2026.
- Over 5 years, Enterprise Value stood at $173.2 million in 2022, then plunged by 71.66% to $49.1 million in 2023, then sank by 126.46% to -$13.0 million in 2024, then jumped by 151.17% to $6.6 million in 2025, then surged by 283.25% to $25.5 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered $25.5 million, $38.9 million, and $6.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 210.98 Bn | 196.99 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 181.24 Bn | 178.06 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.38 Bn | 124.53 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.97 Bn | 74.97 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.59 Bn | 56.41 Bn | 1.37 Bn |
| 6 | Moderna | 54.80 Bn | 49.67 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.09 Bn | 30.78 Bn | 992.69 Mn |
| 8 | Biogen | 31.34 Bn | 30.05 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.11 Bn | 30.11 Bn | 1.16 Mn |
| 10 | TAO Synergies | 30.79 Mn | 30.79 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.47 Mn |
| Mar 31, 2026 | 38.87 Mn |
| Dec 31, 2025 | 6.65 Mn |
| Sep 30, 2025 | 16.70 Mn |
| Jun 30, 2025 | -2.11 Mn |
| Mar 31, 2025 | -11.47 Mn |
| Dec 31, 2024 | -12.99 Mn |
| Sep 30, 2024 | -17.98 Mn |
| Jun 30, 2024 | -22.30 Mn |
| Mar 31, 2024 | -23.17 Mn |
| Dec 31, 2023 | 49.09 Mn |
| Sep 30, 2023 | 86.00 Mn |
| Jun 30, 2023 | 137.97 Mn |
| Mar 31, 2023 | 111.40 Mn |
| Dec 31, 2022 | 173.24 Mn |
| Sep 30, 2022 | 1.12 Bn |
| Jun 30, 2022 | 854.84 Mn |
| Mar 31, 2022 | 1.29 Bn |
| Dec 31, 2021 | 1.03 Bn |
| Sep 30, 2021 | 1.49 Bn |